Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-64,350Price:--
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-62,893Price:$77.00
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:64,350Price:$74.29
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-25,177Price:--
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-25,177Price:$77.00
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:25,177Price:$74.29
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-15,736Price:--
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-10,100Price:--
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-25,836Price:$75.00
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:15,736Price:$74.29
Filings by filing date
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-64,350Price:--
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-62,893Price:$77.00
- Jan 19, 2021 (filed on Jan 21, 2021)Insider Name:Merlo Larry JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:64,350Price:$74.29
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-25,177Price:--
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-25,177Price:$77.00
- Jan 12, 2021 (filed on Jan 13, 2021)Insider Name:Bisaccia LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:25,177Price:$74.29
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-15,736Price:--
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Stock OptionNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-10,100Price:--
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-25,836Price:$75.00
- Jan 08, 2021 (filed on Jan 12, 2021)Insider Name:Lotvin AlanOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:15,736Price:$74.29
News
Biz Brief
Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1 Cvs Dr WOONSOCKET RI 02895-6146 |
Tel: | N/A |
Website: | https://cvshealth.com |
IR: | See website |
Key People | ||
David W. Dorman Independent Chairman of the Board | Joshua M. Flum Executive Vice President - Enterprise Strategy and Digital | Larry J. Merlo President, Chief Executive Officer, Director |
Eva C. Boratto Chief Financial Officer, Executive Vice President | Jonathan C. Roberts Chief Operating Officer, Executive Vice President | Lisa G. Bisaccia Chief Human Resource Officer, Executive Vice President |
Laurie Havanec Chief People Officer, Executive Vice President | Thomas M. Moriarty Executive Vice President, General Counsel, Chief Policy and External Affairs Officer | Troyen A. Brennan Executive Vice President, Chief Medical Officer | Daniel Finke Executive Vice President, President - Health Care Benefits Segment |
Business Overview |
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics. |
Financial Overview |
For the nine months ended 30 September 2020, CVSHealth Corp revenues increased 5% to $199.15B. Net incomeapplicable to common stockholders increased 27% to $6.21B.Revenues reflect Health Care Benefits segment increase of7% to $56.36B, Retail Pharmacy Segment increase of 5% to$67.14B, Comp. Store Sales (Growth - %) - Pharmay increaseof 46% to 6.9%, Retail Sales-Retail Pharmacy increase of 5%to $51.83B. |
Employees: | 290,000 as of Dec 31, 2019 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $151,925M as of Sep 30, 2020 |
Annual revenue (TTM): | $266,041M as of Sep 30, 2020 |
EBITDA (TTM): | $19,007M as of Sep 30, 2020 |
Net annual income (TTM): | $7,956M as of Sep 30, 2020 |
Free cash flow (TTM): | $10,010M as of Sep 30, 2020 |
Net Debt Last Fiscal Year: | $54,908M as of Sep 30, 2020 |
Shares outstanding: | 1,308,913,498 as of Oct 28, 2020 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |